Amebic meningoencephalitis

Karen C Bloch MD MPH

Infectious Disorders

Updated 08.20.2024
Released 01.12.1994
Expires For CME 08.20.2027

Amebic meningoencephalitis

Author: Karen C Bloch MD MPH

See Contributor Disclosures

Editor: Christina M Marra MD

Amebic meningoencephalitis

In This Article

Quick Link

Introduction

Overview

Infection of the central nervous system caused by free-living amebae is rare but usually lethal. There are two distinct presentations of neurologic infections due to these organisms. Primary amebic meningoencephalitis is a fulminant infection caused by Naegleria fowleri that most commonly affects healthy children and teenagers. In contrast, granulomatous amebic encephalitis is a subacute infection caused by Balamuthia mandrillaris or Acanthamoeba species, with the latter occurring almost exclusively in immunocompromised patients. Early diagnosis and prompt treatment with combination antimicrobials has proven lifesaving in some cases for what had previously been almost uniformly fatal infections. In this article, the author reviews the evaluation and management of amebic meningoencephalitis, with an emphasis on new diagnostic modalities and treatment options.

Key points

	• Granulomatous amebic encephalitis is a subacute infection that mimics granulomatous infections such as tuberculous meningitis, often causing CNS mass lesions.
	• Primary amebic meningoencephalitis presents similarly to bacterial meningitis and is usually due to intranasal inoculation of water containing Naegleria.
	• Early treatment with combinations of antimicrobial regimens that include miltefosine may save lives and improve outcome.
	• In cases of suspected amebic meningoencephalitis, the U.S. Centers for Disease Control and Prevention should be contacted (770-488-7100) for diagnostic and clinical assistance.

Historical note and terminology

Free-living amebae were first recognized as causes of mammalian infection in 1958, when monkeys inoculated with Acanthamoeba culbertsoni developed fatal encephalitis (37), with the first human case of granulomatous amebic encephalitis recognized shortly thereafter. Balamuthia mandrillaris was first isolated in 1986 from brain tissue obtained from a baboon who succumbed to encephalitis. Balamuthia, named after the parasitologist Willam Balamuth, was recognized as a distinct genus and species in 1993 (38). The most recently identified free-living ameba to cause human neurologic infection is Sappinia pedate, identified in 2001 in a previously healthy man with a temporal lobe mass lesion (13). However, there have been no subsequent reports of this organism as a human pathogen.

Estimation of the frequency of granulomatous amebic encephalitis is challenging given underdiagnosis and lack of an established surveillance system. There were 109 laboratory-confirmed cases of Balamuthia granulomatous amebic encephalitis in the United States between 1974 and 2016 (06). A case series based on reports to the CDC Free-Living Ameba database identified 122 patients with Acanthamoeba encephalitis in the U.S. between 1956 and 2020 (21). In contrast, primary amebic meningoencephalitis is a reportable disease in the United States. There have been 31 cases reported in the US between 2012 and 2021, with all but three fatal. More information can be found on the CDC website:https://wwwnc.cdc.gov/eid/article/30/4/23-1076_article.

Clinical manifestations

Presentation and course

	• Primary amebic meningoencephalitis is a fulminant infection that clinically resembles bacterial meningitis.
	• Granulomatous amebic encephalitis is characterized by subacute and progressive neurologic dysfunction, with neuroimaging often showing a mass lesion.

CNS infection with free-living amebae can be broadly categorized under two clinical syndromes: primary amebic meningoencephalitis or granulomatous amebic encephalitis. These presentations differ with respect to causative agents, clinical presentation, and host risk factors. Primary amebic meningoencephalitis is caused by infection with Naegleria fowleri. This organism is abundant in fresh water and thrives in warm temperatures. Not surprisingly, most cases of primary amebic encephalitis occur in the summer months, with a history of swimming in fresh water within the week prior to the onset of symptoms (16). The clinical presentation of primary amebic meningoencephalitis mimics bacterial meningitis and is characterized by rapid progression, leading to the popular description of Naegleria as a “brain-eating ameba” in the lay press. The disease course for primary amebic meningoencephalitis is usually fulminant with the abrupt onset of headache, nausea, vomiting, and fever, with rapid evolution to coma. Death typically ensues within a median of five days of symptom onset, usually due to overwhelming encephalitis and cerebral edema (03). The CSF shows a neutrophilic pleocytosis, an elevation in protein, and, not infrequently, hypoglycorrhachia.

In contrast, granulomatous amebic encephalitis caused by Acanthamoeba species and Balamuthia presents as a subacute or chronic process, progressing over weeks to months. Some cases, however, may be more acute with coma and death within 7 to 9 days. Patients may manifest a prodromal flu-like illness with headache and fever. Subsequently, patients with granulomatous amebic encephalitis often develop vomiting, altered mental status, cranial nerve palsies, and seizures, suggesting the possibility of a mass lesion (15). The CSF usually shows a lymphocytic pleocytosis with a normal or near-normal protein and glucose concentration. Patients with immune compromise such as AIDS, or hematopoietic stem cell/organ transplants are more susceptible to granulomatous amebic encephalitis due to Acanthamoeba species (22; 08). However, Acanthamoeba species are increasingly recognized as pathogens in immunocompetent patients as well (09; 01).

Granulomatous amebic encephalitis due to Balamuthia mandrillaris occurs in both immunocompromised and immunocompetent hosts, particularly in children. A summary of patients reported to the CDC identified 109 laboratory-confirmed cases of Balamuthia between 1974 and 2016, 99% of whom had encephalitis, with a disproportionately high number of cases among people of Hispanic ethnicity (06). The clinical picture for Balamuthia is similar to that seen with Acanthamoeba encephalitis, with progressive neurologic decline variably associated with focal signs (eg, hemiparesis), cranial nerve palsies, and a CSF mononuclear pleocytosis; the time from symptom onset to death averages 24 days (06).

Concurrent cutaneous disease, identified in 6% of Balamuthia encephalitis cases and 10% of Acanthamoeba cases, presents as an erythematous indurated plaque, often involving the face and may present a more easily accessible site for diagnostic biopsy (06; 21).

The significance of Sappinia species in causing human disease is controversial. To date there has been a single patient identified—a 38-year-old immunocompetent man with visual disturbances, headache, and a seizure. Brain images showed a solitary mass in the posterior left temporal lobe. Pathologic evaluation revealed necrotizing hemorrhagic inflammation that contained free-living amoebae. This was ultimately identified as Sappinia pedatadiploidea, an organism usually found in soil and tree bark (30). This patient was treated successfully with a sequential regimen of antiamebic drugs (azithromycin, pentamidine, itraconazole, and flucytosine) after surgical excision (14; 13).

Prognosis and complications

Primary amebic meningoencephalitis and granulomatous amebic encephalitis are extremely lethal diseases, and often the diagnosis is only recognized postmortem. Early recognition and initiation of combination therapy, including miltefosine, has led to a slight improvement in outcomes. To date, there have been five patients in North America (one in Mexico, four in the United States) with primary amebic meningoencephalitis who have survived. Three of these cases occurred since 2013, all of whom were 16 years or less in age. Among patients with granulomatous amebic encephalitis, mortality is 90% to 97% (06; 21).

Clinical vignette

A 13-year-old boy was admitted with a 2- to 3-day history of headache, lethargy, and vomiting. His parents recalled a trip to a lake one week prior to presentation, where he engaged in water sports and went cliff diving. On physical examination he was febrile to 39.5ºC with meningeal signs, increased reflexes, and lethargy. Brain CT and MRI scan were normal. The CSF showed increased protein of 300 mg/dL, glucose of 45 mg/dL, and 160 white blood cells/mm3 (65% polymorphonuclear cells). Motile amoebae were observed in a wet mount of the CSF. Despite treatment, he died within three days of admission.

Biological basis

	• Free-living amebae are single-cell organisms that are ubiquitous in the environment.
	• Naegleria fowleri accesses the brain through the cribriform plate and can be transmitted through freshwater exposure or nasal rinses with contaminated water.

Etiology and pathogenesis

Naegleria are frequently present in fresh water, especially warm, stagnant water. These organisms have been identified in 46% of hot springs (10). Naegleria exist in three forms, which are all nucleated: trophozoite, flagellate, and cyst (23). The trophozoite is a motile form that resembles a eukaryotic cell, and it is the stage that causes human infection (18). After placement into distilled water, trophozoites can transform into a distinctive flagellate form; the latter stage appears pear shaped, with two to four flagellae protruding from the anterior end, providing the capacity for rapid motility. Under conditions of stress, such as nutritional deprivation or desiccation, Naegleria form resistant cysts. Clinical specimens typically contain the trophozoite form.

Acanthamoeba species are common inhabitants of soil or hot springs that only exist as trophozoites or double-walled cysts, with no flagellate form (10). The trophozoite form has fine pseudopodia at the leading edge as it moves; these thorn-like spikes give the genus its name, from the Greek word akantha for “thorn.” The cyst form of Acanthamoeba has a more wrinkled appearance than the cyst of Naegleria; this dormant phase can survive in the environment for decades.

Balamuthia mandrillaris is indistinguishable from Acanthamoeba in formalin-fixed tissue examined at the light microscope level; however, there are distinctive differences with respect to ultrastructure, physiology, and antigenicity (17).

Trophozoite forms of Balamuthia mandrillaris in cerebral cortex (photomicrograph)

Trophozoite forms of Balamuthia mandrillaris in cerebral cortex appear as large cells (15 to 40 µm) with vesicular nucleus, prominent nucleolus, and granular eosinophilic cytoplasm. (Courtesy of Dr. David A. Griesemer, Medi...
Cyst form of Balamuthia mandrillaris in cerebral cortex (photomicrograph)

Cyst form of Balamuthia mandrillaris in cerebral cortex is spherical, binucleated with a double-layered irregular cell wall. (Courtesy of Dr. David A. Griesemer, Medical University of South Carolina.)

Pathophysiology. Naegleria thrive in warm, stagnant water. Raised temperatures during the hot summer months, water in hot spring recreational facilities, or warm water from power plants facilitate the growth of N fowleri (31). Classically, primary amebic meningoencephalitis occurs through inoculation of infected water through the cribriform plate. The classic scenario is cliff diving, where water under pressure enters the nasal cavity. Infection through tap water exposure is also a risk factor, and cases have been reported after neti pot nasal irrigation, ritual nasal ablution, use of a slip-n-slide supplied with tap water, and rarely, ingestion of contaminated tap water (04). The agent then spreads along the extensions of the olfactory nerve or blood vessels, spreading throughout the meninges and within the brain (23). The presence of severe amebic involvement of the olfactory regions and frontal regions of the cerebral hemispheres further supports the postulated route of spread. The microscopic pathology is characterized by intense polymorphonuclear (neutrophil and eosinophil) infiltration resulting in necrotizing encephalitis.

The pathogenesis of Acanthamoeba encephalitis is less well understood. It is believed that Acanthamoeba gains access to the brain through intranasal spread through inhalation of airborne dust or water (24). Cutaneous inoculation leading to hematogenous spread is another postulated mechanism of infection. Organisms then multiply intracranially, with resulting edema, hemorrhage, and necrosis; perivascular cuffing by neutrophils, trophozoites, and cysts is often present (23). Granulomatous inflammation is frequently present, although this may be atypical or absent in the profoundly immunocompromised.

Balamuthia mandrillaris has been isolated from soil, dust, and water. The pathogenesis of CNS disease caused by this organism is unclear; however, hematogenous spread is suggested based on clustering of amebae around blood vessels. Transmission through transplantation of organs from an infected donor has also been described (11).

Pathology of brains from patients with Balamuthia infection showed a spectrum of inflammation that ranged from neutrophilic infiltrates to necrotizing granulomas. Microscopically, necrosis and hemorrhagic brain infarction is frequently seen (Zhang and Chen 2021). Trophozoites and cysts can be found in subarachnoid and Virchow-Robin spaces (23).

Epidemiology

Naegleria have been found in thermal discharges of power plants, heated swimming pools, hot springs, hydrotherapy pools, sewage, and even tap water. Among 120 cases of primary amebic encephalitis reported to the CDC, 85 (71%) had recreational water exposure, including lake or pond (69 patients), river or stream (14 patients), or recreational aquatic venue (two patients) (16). Cases have been associated with use of contaminated tap water for nasal irrigation (41) or following ritual nasal ablution (34). Occasional clusters have occurred, usually because of swimming in an inadequately chlorinated swimming pool (29; 36).

As of 2022, a total of 157 cases of primary amebic meningoencephalitis have been reported in the United States, with most cases occurring in Southern states during summer months. However, increasingly cases are identified in Northern states such as Minnesota and Indiana (03). In 2022, cases were reported in Iowa, Nebraska, and Arizona. Primary amebic meningoencephalitis is primarily a pediatric illness, with a median age 11 years. Infections are most common in males (76%), likely related to recreational exposure.

Despite the ubiquity of Acanthaemoeba in the environment, CNS infection with this agent is reported primarily in immunocompromised patients (12; 07; 08; 21). As this is not a reportable disease, scant data exist regarding the epidemiology of Acanthamoeba granulomatous amebic encephalitis, with most information coming from case reports or small case series. There is no clear geographic localization for this infection.

Balamuthia granulomatous amebic encephalitis cases are disproportionately male (68%), and recreational or occupational soil exposure is present in 85% of cases (06). Although previously believed to be a disease of immunocompetent hosts, this study revealed 39% of cases were immunocompromised.

Diagnostic workup

	• Evaluation of fresh, nonrefrigerated CSF may show mobile trophozoites, which is diagnostic of primary amebic meningoencephalitis.
	• Granulomatous amebic encephalitis is often difficult to diagnose without tissue biopsy, but next-generation sequencing of CSF may allow minimally invasive diagnosis.
	• Consultation with experts at the CDC for assistance in diagnostic testing can be obtained by calling 770-488-7100.

Patients with primary amebic meningoencephalitis caused by Naegleria have a clinical syndrome resembling that of acute bacterial meningitis. The CSF shows features characteristic of acute bacterial meningitis with a neutrophilic pleocytosis, elevated protein, and decreased glucose levels. Visualization of motile trophozoites in fresh, nonrefrigerated CSF specimens is considered diagnostic (32). Giemsa-Wright stain or modified trichrome stain of CSF may also demonstrate Naegleria trophozoites. Culture of the organism and detection by polymerase chain reaction are possible but these tests are not uniformly available outside of research settings. Identification of Naegleria in tissue by immunohistochemistry or immunofluorescence can be performed by the Centers for Disease Control and Prevention, with diagnostic assistance available (CDC.gov).

In patients with granulomatous amebic encephalitis, neuroimaging may suggest the diagnosis, although findings are often nonspecific and include single and multifocal parenchymal lesions, ring-enhancing lesions, hydrocephalus, nonspecific white matter lesions, meningeal exudates, hemorrhagic infarcts, or necrosis (33; 19; 02; 26). In contrast to primary amebic meningoencephalitis, organisms are rarely seen in the CSF. Serologic testing is of limited value given the ubiquity of these organisms in nature (23). Diagnostic testing is limited through commercial laboratories, and when granulomatous amebic encephalitis is suspected the CDC free-living and intestinal ameba laboratory can provide assistance through telediagnosis or testing of tissues. PCR testing of formalin-fixed tissue may be useful for detecting free-living amebae in brain tissue (28). CSF evaluation through metagenomic deep sequencing may be diagnostic (39; 40).

Management

	• Treatment of amebic encephalitis is complex, requiring combination therapy with most successful regimens including miltefosine.
	• Consultation with experts at the CDC is highly recommended when treating patients with these infections (770-488-7100).

Early recognition and prompt aggressive management of primary amebic meningoencephalitis and granulomatous amebic encephalitis is critical given the poor prognosis of these infections. There have been no clinical trials to guide optimal treatment, and most recommendations are based on anecdotal reports of success in survivors.

Treatment of primary amebic meningoencephalitis requires combination therapy with a miltefosine-containing regimen (20). This medication is available commercially, with consignment programs allowing on-site stocking of medication (www.impavido.com). Studies show variable penetration of this medication into the cerebrospinal fluid (27). Other agents active against Naegleria include amphotericin B, rifampin, fluconazole, and azithromycin (05). The CDC recommends use of both intravenous and intrathecal amphotericin B deoxycholate for this infection, which is significantly more active than liposomal preparations (23). Dexamethasone is often indicated for treatment of cerebral edema. Specific regimens and dosing should be determined in consultation with experts at the CDC (770-488-7100).

Most cases of granulomatous amebic encephalitis are fatal, with combination therapy offering the best chance of survival for CNS infections with Acanthamoeba and Balamuthia. The use of drug combinations addresses resistance patterns that may exist or develop during treatment, ensuring that at least one of the drugs may be effective against the amoebae. Because of the complexity of treatment, consultation with an expert at the CDC is strongly recommended (770-488-7100). Based on reports of survivorship, the recommended regimen for treatment includes pentamidine IV, sulfadiazine, flucytosine, fluconazole, azithromycin, and miltefosine (23). Miltefosine can be obtained commercially (www.impavido.com), although is not FDA-approved for this indication. A regimen containing nitroxoline, a quinolone antibiotic, was used in the successful treatment of B mandrillaris encephalitis (35). This agent was chosen based on screening of more than 2000 clinically-approved agents to assess for in vitro activity against B mandrillaris (25). This agent has in vitro activity against other free living amebae; however, it is not commercially available in the United States (20).

References

01: Aparicio DV, Bejarano JIC, de Los Santos AM, Ramirez-Cortinas S, de la O Cavazos M. Case report: granulomatous amebic encephalitis due to Acanthamoeba spp. in an immunocompetent pediatric patient. Am J Trop Med Hyg 2021;105(1):167-70. PMID 33970886
02: Berger JR. Amebic infections of the central nervous system. J Neurovirol 2022;28:467-72.** PMID 36098909
03: Capewell LG, Harris AM, Yoder JS, et al. Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937-2013. J Pediatric Infect Dis Soc 2015;4(4):e68-75.** PMID 26582886
04: Cope JR, Ali IK. Primary amebic meningoencephalitis: what have we learned in the last 5 years? Curr Infect Dis Rep 2016;18(10):31.** PMID 27614893
05: Cope JR, Conrad DA, Cohen N, et al. Use of the novel therapeutic agent miltefosine for the treatment of primary amebic meningoencephalitis: report of 1 fatal and 1 surviving case. Clin Infect Dis 2016;62(6):774-6. PMID 26679626
06: Cope JR, Landa J, Nethercut H, et al. The epidemiology and clinical features of Balamuthia mandrillaris disease in the United States, 1974-2016. Clin Infect Dis 2019;68(11):1815-22.** PMID 30239654
07: Crothers JW, Hsu L, Marty FM. Fulminant Acanthamoeba castellanii encephalitis in an ibrutinib-treated patient. Open Forum Infect Dis 2020;7(2):ofaa025. PMID 32055639
08: Damhorst GL, Watts A, Hernandez-Romieu A, et al. Acanthamoeba castellanii encephalitis in a patient with AIDS: a case report and literature review. Lancet Infect Dis 2022;22:e59-e65. PMID 34461057
09: Das S, Gunasekaran K, Ajjampur SSR, et al. Acanthamoeba encephalitis in immunocompetent hosts: a report of two cases. Med Prim Care 2020;9(2):1240-3. PMID 32318505
10: Fabros MRL, Diesta XRS, Oronan JA, et al. Current report on the prevalence of free-living amoebae (FLA) in natural hot springs: a systematic review. J Water Health 2021;19:563-574. PMID 34371494
11: Farnon EC, Kokko KE, Budge PJ, et al. Transmission of Balamuthia mandrillaris by Organ Transplantation. Clin Infect Dis 2016;63:878-88. PMID 27358357
12: Geith S, Walochnik J, Prantl F, Sack S, Eyer F. Lethal outcome of granulomatous acanthamoebic encephalitis in a man who was human immunodeficiency virus-positive: a case report. J Med Case Rep 2018;12(1):201. PMID 29996943
13: Gelman BB, Popov V, Chaljub G, et al. Neuropathological and ultrastructural features of amebic encephalitis caused by Sappinia diploidea. J Neuropathol Exp Neurol 2003;62(10):990-8. PMID 14575235
14: Gelman BB, Rauf SJ, Nader R, et al. Amoebic encephalitis due to Sappinia diploidea. JAMA 2001;285(19):2450-1. PMID 11368696
15: Gharpure R, Bliton J, Goodman A, Ali IKM, Yoder J, Cope JR. Epidemiology and clinical characteristics of primary amebic meningoencephalitis caused by Naegleria fowleri: a global review. Clin Infect Dis 2021a;73:e19-e27. PMID 32369575
16: Gharpure R, Gleason M, Salah Z, et al. Geographic range of recreational water–associated primary amebic meningoencephalitis, United States, 1978–2018. Emerg Infect Dis 2021b;27(1):271-4. PMID 33350926
17: Griesemer DA, Barton LL, Reese CM, et al. Amebic meningoencephalitis caused by Balamuthis mandrillaris. Pediatr Neurol 1994;10:249-54. PMID 8060431
18: Harris GR, Batra R. Naegleria fowleri. N Engl J Med 2020;383(11):1057. PMID 32905679
19: Harrison WT, Lecky B, Hulette CM. Fatal granulomatous amebic encephalitis in a heart transplant patient: clinical, radiographic, and autopsy findings. J Neuropathol Exp Neurol 2018;77(11):1001-4. PMID 30295806
20: Haston JC, Cope JR. Amebic encephalitis and meningoencephalitis: an update on epidemiology, diagnostic methods, and treatment. Curr Opin Infect Dis 2023;36(3):186-91. PMID 37093056
21: Haston JC, O'Laughlin K, Matteson K, et al. The epidemiology and clinical features of non-keratitis Acanthamoeba infections in the United States, 1956-2020. Open Forum Infect Dis 2023;10(1).** PMID 36655187
22: Keane NA, Lane LM, Canniff E, et al. A surviving case of Acanthamoeba granulomatous amebic encephalitis in a hematopoietic stem cell transplant recipient. Am J Case Rep 2020;21:e923219. PMID 32603318
23: Kofman A, Guarner J. Free living amoebic infections: review. J Clin Microbiol 2021;JCM0022821. PMID 34133896
24: Kot K, Łanocha-Arendarczyk N, Kosik-Bogacka D. Immunopathogenicity of Acanthamoeba spp. in the brain and lungs. Int J Mol Sci 2021;22(3):1261. PMID 33514026
25: Laurie MT, White CV, Retallack H, et al. Functional assessment of 2,177 U.S. and international drugs identifies the quinoline nitroxoline as a potent amoebicidal agent against the pathogen Balamuthia mandrillaris. mBio 2018;e02051-18. PMID 30377287
26: Levinson S, Kumar KK, Wang H, et al. Balamuthia mandrillaris brain infection: a rare cause of a ring-enhancing central nervous system lesion. Illustrative case. J Neurosurg Case Lessons 2022;3(15):CASE2268. PMID 36303497
27: Monogue ML, Watson D, Alexander JS, et al. Minimal cerebrospinal fluid concentration of miltefosine despite therapeutic plasma levels during the treatment of amebic encephalitis. Antimicrob Agents Chemother 2019;64(1):e01127-19. PMID 31685474
28: Norgan AP, Sloan LM, Pritt BS. Detection of Naegleria fowleri, Acanthamoeba spp, and Balamuthia mandrillaris in formalin-fixed, paraffin-embedded tissues by real-time multiplex polymerase chain reaction. Am J Clin Pathol 2019;152(6):799-807. PMID 31415080
29: Paknejad N, Hajialilo E, Saraei M, Javadi A. Isolation and identification of Acanthamoeba genotypes and Naegleria spp. from the water samples of public swimming pools in Qazvin, Iran. J Water Health 2020;18(2):244-51. PMID 32300097
30: Qvarnstrom Y, da Silva AJ, Schuster FL, Gelman BB, Visvesvara GS. Molecular confirmation of Sappinia pedata as a causative agent of amoebic encephalitis. J Infect Dis 2009;199(8):1139-42. PMID 19302010
31: Ramirez-Flores E, Bonilla-Lemus P, Carrasco-Yépez MM, et al. Saline-tolerant pathogenic Acanthamoeba spp. isolated from a geothermal power plant. Pathogens 2023;12(11):1363. PMID 38003827
32: Rojo JU, Rajendran R, Salazar JH. Laboratory diagnosis of primary amoebic meningoencephalitis. Lab Med 2023;54(5):e124-32. PMID 36638160
33: Schimmel M, Mehta I. Granulomatous amebic encephalitis. N Engl J Med 2020;383:1262. PMID 32966724
34: Shakoor S, Beg MA, Mahmood SF, et al. Primary amebic meningoencephalitis caused by Naegleria fowleri, Karachi, Pakistan. Emerg Infect Dis 2011;17(2):258-61. PMID 21291600
35: Spottiswoode N, Pet D, Kim A, et al. Successful treatment of Balamuthia mandrillaris granulomatous amebic encephalitis with nitroxoline. Emerg Infect Dis 2023;29:197-201. PMID 36573629
36: Solis-Castro ME. Lethal encephalitis due to free-living amoebae in three members of a family, in Tumbes, Peru. Rev Peru Med Exp Salud Publica 2021;38:291-5. PMID 34468578
37: Visvesvara GS. Infections with free-living amebae. Handb Clin Neurol 2013;114:153-68.** PMID 23829906
38: Visvesvara GS, Martinez AJ, Schuster FL, et al. Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals. J Clin Microbiol 1990;28:2750-6. PMID 2280005
39: Wilson MR, Shanbhag NM, Reid MJ, et al. Diagnosing Balamuthia mandrillaris encephalitis with metagenomic deep sequencing. Ann Neurol 2015;78(5):722-30. PMID 26290222
40: Xu C, Wu X, Tan M, Wang D, Wang S, Wu Y. Subacute Balamuthia mandrillaris encephalitis in an immunocompetent patient diagnosed by next-generation sequencing. J Int Med Res 2022;50:3000605221093217. PMID 35505464
41: Yoder JS, Straif-Bourgeois S, Roy SL, et al. Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water. Clin Infect Dis 2012;55(9):e79-85. PMID 22919000
42: Zhang H, Cheng X. Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease. Front Med 2021;15(6):842-66. PMID 34825341

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Karen C Bloch MD MPH

Dr. Bloch of Vanderbilt University Medical Center has no relevant financial relationships to disclose.
See Profile

Editor

Christina M Marra MD

Dr. Marra of the University of Washington School of Medicine has no relevant financial relationships to disclose.
See Profile

Former Authors

Raymond P Roos MD
Mark A Stacy MD
Sith Sathornsumetee MD

Patient Profile

Age range of presentation: can occur at any age
Sex preponderance: male>female
Heredity: none
Population groups selectively affected: Immunocompromised hosts are more susceptible in Acanthamoeba and to a lesser degree, Balamuthia meningoencephalitis.
Occupation groups selectively affected: Individuals who engage in outdoor occupations with significant soil exposure (such as gardening, construction, etc.) have an increased risk of Balamuthia granulomatous amebic encephalitis.

ICD & OMIM codes

ICD-10: Naegleriasis: B60.2

Meningoencephalitis due to Acathamoeba: B60.11

Amebic brain abscess: AO6.6
ICD-11: Amoebiasis: 1A36

Naegleriasis: 1F55

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Amebic meningoencephalitis

Associated Disorders

Meningitis

Differential Diagnosis

bacterial brain abscess
toxoplasmosis
mass lesion
acute bacterial meningitis
tuberculosis
- fungal infections
- granulomatous encephalitis
- tumors
- progressive or atypical strokes

Also Relevant

Fever: neurologic causes and complications

Clinical Categories

Infectious Disorders

Web References

Clinical Trials

NIH: Meningitis

Amebic meningoencephalitis

Amebic meningoencephalitis

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Prion diseases

Rabies

Malaria

Neuropathies associated with cytomegalovirus infection

Genital herpes: neurologic complications

Neurocysticercosis

Trichinosis

Zika virus: neurologic complications

Amebic meningoencephalitis

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Prion diseases

Rabies

Malaria

Neuropathies associated with cytomegalovirus infection

Genital herpes: neurologic complications

Neurocysticercosis

Trichinosis

Zika virus: neurologic complications

This is an article preview.
Start a Free Account
to access the full version.